drugset / Trial / NCT00125957
The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
Phase 3
Completed
32 enrolled
Mclean Hospital
National Association for Research on Schizophrenia and Affective Disorders. · collab
RandomizedCrossoverTriple-blindTreatment
Summary
Many people with depression are treated with a serotonin-specific reuptake inhibitor anti-depressant (SSRI) and feel 'better'. Although many people feel 'better', they do not feel completely 'well'. Often, individuals continue to complain of cognitive problems such as lack of attention, diminished motivation, and impaired problem-solving. This study looks at whether residual and cognitive symptoms of depression in individuals are affected by the addition of Wellbutrin (bupropion).
Timeline
- Start
- 2005-08
- Primary completion
- 2010-01
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | 100 mg | — |
| Subject | Bupropion | Small molecule | 150 mg | — |